DoW Joint Warfighter Medical, Military Medical Research and Development Award
Open Posted
- Opportunity number
- HT942526JWMRPMMRDA
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement, Grant, Other, Procurement Contract
- Category
-
- Science and Technology and other Research and Development
- Eligible applicants
-
- Unrestricted
- Points of contact
-
- eBRAP Help Desk help@ebrap.org (301) 682-5507
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Defense Health Agency is soliciting applications for the Military Medical Research and Development Award (MMRDA) mechanism under the Joint Warfighter Medical Research Program, with full applications due November 16, 2026. Applicants must have previously received Department of War or Department of Defense core or Congressional Special Interest funding; new project concepts and basic research are not supported.
The CDMRP expects to allocate approximately $8.8 million to fund approximately two MMRDA awards with cost caps of $1.4 million each and approximately two MMRDA-Clinical Research or Clinical Trial Option (MMRDA-CRCTO) awards with cost caps of $3.0 million each. The maximum period of performance is three years, with funds expiring for use on September 30, 2032 and awards anticipated by September 30, 2027.
Eligible applicants include extramural and intramural Department of War organizations, including academic institutions, biotechnology companies, and federal agencies; Federally Funded Research and Development Centers may participate in teaming arrangements but cannot directly receive awards. Research must address at least one of five focus areas: non-vaccine approaches to prevent endemic diarrheal disease and broad-spectrum antivirals; hemorrhage mitigation and trauma resuscitation; temperature extreme injury solutions; forward treatment of musculoskeletal injuries; and radiation medical countermeasures. Projects must achieve Technology Readiness Level 5 or greater or Knowledge Readiness Level 5 or greater, spanning late-stage preclinical studies, technology development, demonstration, translational, and clinical research.
The two-step process requires preapplications through eBRAP by August 18, 2026 at 5:00 p.m. Eastern Time, with full application invitations issued by September 21, 2026. Extramural organizations submit full applications through Grants.gov; intramural DOW organizations submit through eBRAP. Peer review is scheduled for February 2027 and programmatic review for April/May 2027. Funding Instrument: 12.420.
Synopsis
Summary: The fiscal year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) mechanism is intended to fund the logical continuation of previous Department of War (DOW)-funded research and development efforts relevant to the FY26 JWMRP that augment and accelerate high-priority medical requirements to meet the needs of Service Members and other Military Health System beneficiaries. The MMRDA supports a wide range of research projects spanning late-stage preclinical studies, late-state technology development efforts, technology demonstration, translational, and clinical research. Projects must be relevant to at least one of the FY26 JWMRP focus areas.
Distinctive Features:
To be eligible for JWMRP funding, applicants/offerors must have already received DOD/DOW core or DOD/DOW Congressional Special Interest funding.
An MMRDA Clinical Research or Clinical Trial Option (MMRDA-CRCTO) is available to specifically support clinical research/observational studies, all phases of clinical trials/interventional studies, and/or correlative studies in support of the development of promising pharmaceutical or biologic candidates, medical devices and technologies. Applicants/offerors should select MMRDA-CRCTO when the application/proposal involves research that includes any human subjects, human biological samples (prospective or retrospective) or human data sets. Note: If selecting this option, applicants must submit additional relevant application/proposal materials.
Files
| File | Type | Posted |
|---|---|---|
| PKG00293368.pdf | ||
| HT942526JWMRPMMRDA_GG2.pdf | ||
| HT942526JWMRPMMRDA_GG.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity